Mira, Leomar T.

HRN: 23-67-49  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
CEFUROXIME 1.5GM (VIAL)
09/06/2023
09/12/2023
IV
1.5g
Q8h
Cap Mr
Waiting Final Action 
09/06/2023
LEVOFLOXACIN 500MG (TAB)
09/06/2023
09/12/2023
ORAL
500mg
OD
Cap Mr, T/c Immunocompromised State
Waiting Final Action 
09/11/2023
AZITHROMYCIN 500MG TABLET (TAB)
09/11/2023
09/17/2023
PO
500 Mg/tab, 1 Tab
OD
Cap MR In The Immunocompromised
Waiting Final Action 
09/15/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
09/09/2023
09/23/2023
PO
10cc
TID
Oral Thrush
Waiting Final Action 
09/15/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/15/2023
09/22/2023
IV
4.5g
Q6H
CAP MR
09/15/2023
FLUCONAZOLE 50MG (CAP)
09/15/2023
09/22/2023
PO
200mg
OD
Oral Thrush
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: